Mycophenolate mofetil non-inferior to prednisone for first-episode nephrotic syndrome in children
Mycophenolate Mofetil Offers Alternative to Steroids for Nephrotic Syndrome
This phase 3 non-inferiority trial randomized 272 children aged 1-10 years with first-episode steroid-sensitive nephrotic syndrome to mycoph…
A new trial shows mycophenolate mofetil works as well as prednisone for children with nephrotic syndrome, with fewer steroid side effects.
Switching therapy after rituximab resistance in AQP4-IgG+ NMOSD shows variable relapse outcomes
New Hope for Tough-to-Treat Nerve Disorder
This single-center, retrospective case series of 10 adults with AQP4-IgG+ NMOSD who were resistant to rituximab evaluated switching therapy.
Patients with a rare nerve disease who stopped responding to standard treatment found relief after switching to new therapies that prevented…
Nailfold videocapillaroscopy patterns associate with interstitial lung disease and skin fibrosis in systemic sclerosis patients
Does the tiny pattern in your nailbeds predict serious lung scarring in scleroderma?
This prospective cross-sectional study evaluated 70 patients with systemic sclerosis to assess associations between nailfold videocapillaros…
Tiny changes under fingernails can warn of serious lung scarring in scleroderma patients, linking nail patterns to disease severity and qual…
Individualized insulin strategies may improve glycemic control in pediatric T1DM with exogenous insulin antibody syndrome
Can personalized insulin plans help kids with a rare, stubborn form of diabetes?
A retrospective case series of 5 pediatric patients with T1DM complicated by exogenous insulin antibody syndrome found that individualized i…
Doctors helped four of five children with rare diabetes stay in a healthy blood sugar range over 70% of the time using personalized treatmen…